Cargando…
In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier
BACKGROUND: The use of siRNA-based gene silencing has been recently underscored as a potential therapeutic strategy for the treatment of neurological disorders. However, the stability of siRNA and other small molecule therapeutics is challenged by their intrinsic instability and limited passage acro...
Autores principales: | Sajja, Ravi K., Cudic, Predrag, Cucullo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505199/ https://www.ncbi.nlm.nih.gov/pubmed/31068126 http://dx.doi.org/10.1186/s12868-019-0504-x |
Ejemplares similares
-
Odorranalectin Is a Small Peptide Lectin with Potential for Drug Delivery and Targeting
por: Li, Jianxu, et al.
Publicado: (2008) -
Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood–Brain Barrier Endothelial Dysfunction In Vitro
por: Sajja, Ravi K., et al.
Publicado: (2015) -
Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line
por: Sajja, Ravi K, et al.
Publicado: (2014) -
Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration
por: Festoff, Barry W., et al.
Publicado: (2017) -
HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016)